Europe is facing a growing threat from chikungunya, a viral disease historically confined to tropical and subtropical regions. Recent outbreaks and rising temperatures are raising concerns among health officials, with Austria among the countries now considered at risk this summer. The increasing prevalence of the Asian tiger mosquito, a key vector for the virus, is a primary driver of this expanding threat.
In 2023 alone, 27 chikungunya outbreaks were reported across Europe, a figure experts believe could significantly increase in the coming years. The disease, characterized by high fever, intense joint and muscle pain, and headaches, can likewise manifest as a rash resembling sunburn, but appearing in unusual locations without causing pain. The European Centre for Disease Prevention and Control (ECDC) believes there is a high likelihood of the virus establishing itself across the continent due to climate change. Experts warn that the situation is becoming more problematic than previously thought.
Chikungunya’s Spread Linked to Climate Change
Chikungunya fever is transmitted primarily by the yellow fever mosquito and, increasingly, the Asian tiger mosquito. While the yellow fever mosquito isn’t yet widespread on mainland Europe, the Asian tiger mosquito is rapidly expanding its range due to warmer temperatures and milder winters. The Austrian Agency for Health and Food Safety (AGES) reported detecting the virus in all Austrian provinces for the first time in 2022, indicating a clear shift in the disease’s geographic reach.
Most cases in Europe have historically been linked to travelers returning from affected regions. However, local transmission is becoming more common in areas where the Asian tiger mosquito is established, such as parts of France and Italy since 2007. This shift from imported cases to locally acquired infections underscores the growing risk to European populations.
Symptoms and Impact of Chikungunya Fever
The name “chikungunya” itself—derived from a Makonde word—describes a key symptom of the disease: “the bent walking one.” This refers to the severe joint pain that often accompanies the fever, which can persist for weeks or even months after the initial infection subsides. Other common symptoms include high fever, muscle aches, and headaches. A non-itchy rash, similar in appearance to sunburn, can also develop in atypical areas of the body.
While chikungunya is rarely fatal, the prolonged joint pain can be debilitating, significantly impacting quality of life. There is currently no specific antiviral treatment for chikungunya fever, so management focuses on relieving symptoms, such as pain, and fever. Preventing mosquito bites remains the most effective way to avoid infection.
Austria Faces Increased Risk This Summer
Recent reports from Austria indicate a heightened concern about the potential for local transmission of chikungunya this summer. The Kurier newspaper reported a “shocking” increase in the risk, prompting health authorities to prepare for potential outbreaks.
The combination of warmer temperatures, increased travel, and the expanding range of the Asian tiger mosquito creates a perfect storm for the virus to spread. Public health officials are urging residents to take precautions against mosquito bites, including using insect repellent, wearing long sleeves and pants, and eliminating standing water where mosquitoes can breed.
Ongoing Monitoring and Future Outlook
The ECDC is continuously monitoring the situation and providing guidance to member states on surveillance, prevention, and control measures. Recent reports highlight the need for continued vigilance and preparedness as the risk of chikungunya transmission in Europe remains elevated.
The next official update on the communicable disease situation in Europe is expected from the ECDC in early May. As the climate continues to change, the threat of chikungunya and other vector-borne diseases is likely to persist, requiring ongoing investment in surveillance, research, and public health infrastructure.
This is a developing story. Share your thoughts and experiences in the comments below.
